Spots Global Cancer Trial Database for stem cell infusion
Every month we try and update this database with for stem cell infusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HD Melphalan and SCT in Patients With IGDD or LCDD | NCT00681044 | Multiple Myelom... | filgrastim melphalan Stem Cell Infus... | 18 Years - 120 Years | Boston Medical Center | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis | NCT00075608 | Multiple Myelom... Plasma Cell Neo... | filgrastim melphalan autologous stem... stem cell infus... | 18 Years - 65 Years | Boston Medical Center | |
| Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | NCT00539500 | Neuroblastoma | Carboplatin Etoposide Melphalan Stem Cell Infus... ClinicMACS | - | M.D. Anderson Cancer Center | |
| URMC Related Haplo-identical Donor BMT | NCT02660281 | Hematological D... Immune Deficien... Solid Tumors Myelofibrosis Multiple Myelom... Lymphoma | Total Body Irra... Fludarabine Pre-Stem Cell I... Pre-Stem Cell I... Busulfan Melphalan Stem Cell Infus... Post-Stem Cell ... Post-Stem Cell ... Thiotepa | 6 Months - 75 Years | University of Rochester | |
| URMC Related Haplo-identical Donor BMT | NCT02660281 | Hematological D... Immune Deficien... Solid Tumors Myelofibrosis Multiple Myelom... Lymphoma | Total Body Irra... Fludarabine Pre-Stem Cell I... Pre-Stem Cell I... Busulfan Melphalan Stem Cell Infus... Post-Stem Cell ... Post-Stem Cell ... Thiotepa | 6 Months - 75 Years | University of Rochester | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib | NCT02489500 | AL Amyloidosis | Bortezomib Melphalan Neupogen Stem Cell Colle... Stem cell infus... | 18 Years - | Boston Medical Center | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis | NCT00790647 | Multiple Myelom... | filgrastim bortezomib melphalan Stem Cell Infus... | 18 Years - 65 Years | Boston Medical Center | |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene | NCT01875237 | Leukemia Myeloma Myeloproliferat... | Fludarabine Melphalan Alemtuzumab Stem Cell infus... Tacrolimus Mini Methotrexa... G-CSF Donor Lymphocyt... AP1903 Methylprednisol... Questionnaire | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation | NCT01653418 | Multiple Myelom... | Bortezomib Carmustine Etoposide Cytarabine Melphalan Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma | NCT01538472 | Lymphoma | Y Zevalin In Zevalin Rituxan BCNU VP -16 Ara-C Melphalan Stem Cell Infus... G-CSF | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma | NCT01538472 | Lymphoma | Y Zevalin In Zevalin Rituxan BCNU VP -16 Ara-C Melphalan Stem Cell Infus... G-CSF | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning | NCT01572662 | Leukemia Acute Myeloid L... Acute Lymphocyt... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Non-Hodgkins Ly... Hodgkins Lympho... Multiple Myelom... Myelodysplastic... | Fludarabine mon... Busulfan Stem Cell Infus... Tacrolimus Methotrexate G-CSF | 5 Years - 75 Years | M.D. Anderson Cancer Center | |
| Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer | NCT00429572 | Breast Cancer | Fludarabine Melphalan Stem Cell Infus... | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| HD Melphalan and SCT in Patients With IGDD or LCDD | NCT00681044 | Multiple Myelom... | filgrastim melphalan Stem Cell Infus... | 18 Years - 120 Years | Boston Medical Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases | NCT00056966 | Hematologic Mal... | ANTI-CD45 CAMPATH-1H FK506 Fludarabine Total Body Irra... Stem cell infus... | - | Baylor College of Medicine | |
| Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden | NCT00651937 | Multiple Myelom... Primary Amyloid... | Melphalan Stem Cell Infus... Questionnaires Granulocyte-col... Apheresis | 60 Years - | M.D. Anderson Cancer Center | |
| Lenalidomide and High-Dose Melphalan | NCT01079936 | Myeloma Stem Cell Trans... | Lenalidomide Melphalan Stem Cell Infus... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis | NCT00075608 | Multiple Myelom... Plasma Cell Neo... | filgrastim melphalan autologous stem... stem cell infus... | 18 Years - 65 Years | Boston Medical Center | |
| T-Reg Cell Kinetics, Stem Cell Transplant, REGALE | NCT00578539 | Leukemia Hodgkin Lymphom... Non Hodgkin Lym... Myeloproliferat... | ARA C Cyclophosphamid... MESNA Total Body Irra... Campath-1h Stem Cell Infus... | - | Baylor College of Medicine | |
| Lenalidomide and High-Dose Melphalan | NCT01079936 | Myeloma Stem Cell Trans... | Lenalidomide Melphalan Stem Cell Infus... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases | NCT00056966 | Hematologic Mal... | ANTI-CD45 CAMPATH-1H FK506 Fludarabine Total Body Irra... Stem cell infus... | - | Baylor College of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
